Article Sidebar

PDF
Date Published: 05/05/2021
Abstract Views: 483
Views PDF: 340
DOI: https://doi.org/10.51298/vmj.v498i2.160
Issue
Vol. 498 No. 2 (2021)
Section
Các bài báo
How to Cite
Văn Chủ, N., & Lê Giang, T. (2021). MSI STATUS OF COLORECTAL ADENOCARCINOMA IN STAGE I-II. Vietnam Medical Journal, 498(2). https://doi.org/10.51298/vmj.v498i2.160

MSI STATUS OF COLORECTAL ADENOCARCINOMA IN STAGE I-II

Nguyễn Văn Chủ, Trần Lê Giang

Main Article Content

Abstract

Background: Microsatellite instability status (MSI) has been identified as a reliable prognostic indicator in stage I-II CRC, with an additional role in predicting the lack of benefit of 5-FU-based adjuvant chemotherapy. Purpose: To review some relationships between MSI status, clinical patterns and stages, pathological characteristics in colorectal cancer. Methods: 53 patients were diagnosed as colorectal adenocarcinoma in stage I-II that are evaluated by pathological features, and IHC stain with MLH1, MSH2, MSH6, PMS2. Results: MSI-H tumors had a higher incidence than MSS / MSI-L tumors in stage I and lower in stage II (32.2; 68.8 vs. 24.3; 75.7% respectively). Conclusion: MSI-H CRCs has a higher incidence than MSS / MSI-L tumors in stage I and lower in stage II. In which, the LS pattern has a high rate in stage II and the lowest in stage I.

Article Details

Keywords

MSI, Histopathology and Immunohistochemistry

References

1. Cunningham, JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ, Halling KC, McDonnell SK, Schaid DJ, Walsh Vockley C, Kubly V, Nelson H, Michels VV, Thibodeau SN (2001), “The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinoma”, Am J Hum Genet, 69: 780-790. .
2. De, la Chapelle A (2004), “Genetic predisposition to colorectal cancer”, Nat Rev Cancer, 769-780.
3. Greenson, JK, Bonner JD, Ben-Yzhak O, Cohen HI, Miselevich I, Resnick MB, Trougouboff P, Tomsho LD, Kim E, Low M, Almog R, Rennert G, Gruber SB. Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol 2003; 27: 563- 570.
4. Hall, G, Clarkson A, Shi A, Langford E, Leung H, Eckstein RP, Gill AJ. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair defciency screening in colorectal adenocarcinoma. Path- ology 2010; 42: 409-413.
5. Kurzawski, G, J. Suchy, T. De ˛bniak (2004). Importance of microsatellite instability (MSI) in colorectal cancer: MSI as a diagnostic tool. Annals of Oncology 15 (Supplement 4): iv283 – iv284.
6. Amin, MB et al. AJCC Cancer Staging Manual eighth edition. Springer, 2017, 251-395.
7. Boland, CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010; 138: 2073-2087.
8. Umar, A, Boland CR, Terdiman JP et al (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syn- drome) and microsatellite instability. J Natl Cancer Inst 2004; 96: 261-268.
9. Jenkins, MA , Hayashi S, O’shea AM et al. Pathology Features in Bethesda Guidelines Predict Colorectal Cancer Microsatellite Instability: A Population-Based Study. Gastroenterology. 2007 July ; 133(1): 48–56.